Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.16T, Eli Lilly(LLY) trades at $1,233.00. The stock has a price-to-earnings ratio of 43.49 and currently yields dividends of 0.53%.
On 2026-06-29, Eli Lilly(LLY) stock moved within a range of $1,203.14 to $1,238.00. With shares now at $1,233.00, the stock is trading +2.5% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 3.68M, compared to an average daily volume of 3.57M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,238.00 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,238.00 and a low of $623.78.
LLY News
Eli Lilly (NYSE:LLY) has entered a research and collaboration agreement with BioArctic focused on neurodegenerative disease treatments. The partnership centers...
Eli Lilly (LLY) is one of the first companies to be selected for a U.S. Food and Drug Administration (FDA) pilot program that’s designed to accelerate reviews o...
Eli Lilly (LLY), Regeneron (REGN), Amneal (AMRX), Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will parti...
Analyst ratings
84%
of 31 ratingsMore LLY News
Key Points Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in...
The stock of Eli Lilly (LLY) hit an all-time high on June 29 as the pharmaceutical company’s weight-loss drug sales accelerate and excitement builds for upcomin...
Eli Lilly LLY shares ended the last trading session 7.1% higher at $1. The jump came on an impressive volume with a higher-than-average number of shares changin...
Eli Lilly (NYSE: LLY) is benefiting from its blockbuster weight loss treatment. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double D...
Key Points Eli Lilly's leukemia drug is making progress toward regulatory approval in the EU. The healthcare leader's weight-loss drugs will soon be more affo...
Key Points Eli Lilly leads in next‑gen obesity drugs, while Novo Nordisk offers a cheaper, dividend‑paying alternative. Novo’s steady insulin cash flows and n...
Eli Lilly (LLY) is back in focus for investors after its recent share performance, with the stock closing at $1,127.69 and sitting within a large pharmaceutical...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.